The BRAF V600K mutant melanoma is more frequently associated with older age, male gender [133], and scalp location [134] and have demonstrated more-aggressive behaviour than BRAF V600E, with an inferior response to treatment and shorter progression-free survival after a combination of BRAF and MEK inhibitors [135]. The gene discussed is MAP2K7; the disease is melanoma.